Cargando…

Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays

A major problem for the effective diagnosis and management of prion diseases is the lack of rapid high-throughput assays to measure low levels of prions. Such measurements have typically required prolonged bioassays in animals. Highly sensitive, but generally non-quantitative, prion detection method...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilham, Jason M., Orrú, Christina D., Bessen, Richard A., Atarashi, Ryuichiro, Sano, Kazunori, Race, Brent, Meade-White, Kimberly D., Taubner, Lara M., Timmes, Andrew, Caughey, Byron
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996325/
https://www.ncbi.nlm.nih.gov/pubmed/21152012
http://dx.doi.org/10.1371/journal.ppat.1001217
_version_ 1782193184060735488
author Wilham, Jason M.
Orrú, Christina D.
Bessen, Richard A.
Atarashi, Ryuichiro
Sano, Kazunori
Race, Brent
Meade-White, Kimberly D.
Taubner, Lara M.
Timmes, Andrew
Caughey, Byron
author_facet Wilham, Jason M.
Orrú, Christina D.
Bessen, Richard A.
Atarashi, Ryuichiro
Sano, Kazunori
Race, Brent
Meade-White, Kimberly D.
Taubner, Lara M.
Timmes, Andrew
Caughey, Byron
author_sort Wilham, Jason M.
collection PubMed
description A major problem for the effective diagnosis and management of prion diseases is the lack of rapid high-throughput assays to measure low levels of prions. Such measurements have typically required prolonged bioassays in animals. Highly sensitive, but generally non-quantitative, prion detection methods have been developed based on prions' ability to seed the conversion of normally soluble protease-sensitive forms of prion protein to protease-resistant and/or amyloid fibrillar forms. Here we describe an approach for estimating the relative amount of prions using a new prion seeding assay called real-time quaking induced conversion assay (RT-QuIC). The underlying reaction blends aspects of the previously described quaking-induced conversion (QuIC) and amyloid seeding assay (ASA) methods and involves prion-seeded conversion of the alpha helix-rich form of bacterially expressed recombinant PrP(C) to a beta sheet-rich amyloid fibrillar form. The RT-QuIC is as sensitive as the animal bioassay, but can be accomplished in 2 days or less. Analogous to end-point dilution animal bioassays, this approach involves testing of serial dilutions of samples and statistically estimating the seeding dose (SD) giving positive responses in 50% of replicate reactions (SD(50)). Brain tissue from 263K scrapie-affected hamsters gave SD(50) values of 10(11)-10(12)/g, making the RT-QuIC similar in sensitivity to end-point dilution bioassays. Analysis of bioassay-positive nasal lavages from hamsters affected with transmissible mink encephalopathy gave SD(50) values of 10(3.5)–10(5.7)/ml, showing that nasal cavities release substantial prion infectivity that can be rapidly detected. Cerebral spinal fluid from 263K scrapie-affected hamsters contained prion SD(50) values of 10(2.0)–10(2.9)/ml. RT-QuIC assay also discriminated deer chronic wasting disease and sheep scrapie brain samples from normal control samples. In principle, end-point dilution quantitation can be applied to many types of prion and amyloid seeding assays. End point dilution RT-QuIC provides a sensitive, rapid, quantitative, and high throughput assay of prion seeding activity.
format Text
id pubmed-2996325
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-29963252010-12-10 Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays Wilham, Jason M. Orrú, Christina D. Bessen, Richard A. Atarashi, Ryuichiro Sano, Kazunori Race, Brent Meade-White, Kimberly D. Taubner, Lara M. Timmes, Andrew Caughey, Byron PLoS Pathog Research Article A major problem for the effective diagnosis and management of prion diseases is the lack of rapid high-throughput assays to measure low levels of prions. Such measurements have typically required prolonged bioassays in animals. Highly sensitive, but generally non-quantitative, prion detection methods have been developed based on prions' ability to seed the conversion of normally soluble protease-sensitive forms of prion protein to protease-resistant and/or amyloid fibrillar forms. Here we describe an approach for estimating the relative amount of prions using a new prion seeding assay called real-time quaking induced conversion assay (RT-QuIC). The underlying reaction blends aspects of the previously described quaking-induced conversion (QuIC) and amyloid seeding assay (ASA) methods and involves prion-seeded conversion of the alpha helix-rich form of bacterially expressed recombinant PrP(C) to a beta sheet-rich amyloid fibrillar form. The RT-QuIC is as sensitive as the animal bioassay, but can be accomplished in 2 days or less. Analogous to end-point dilution animal bioassays, this approach involves testing of serial dilutions of samples and statistically estimating the seeding dose (SD) giving positive responses in 50% of replicate reactions (SD(50)). Brain tissue from 263K scrapie-affected hamsters gave SD(50) values of 10(11)-10(12)/g, making the RT-QuIC similar in sensitivity to end-point dilution bioassays. Analysis of bioassay-positive nasal lavages from hamsters affected with transmissible mink encephalopathy gave SD(50) values of 10(3.5)–10(5.7)/ml, showing that nasal cavities release substantial prion infectivity that can be rapidly detected. Cerebral spinal fluid from 263K scrapie-affected hamsters contained prion SD(50) values of 10(2.0)–10(2.9)/ml. RT-QuIC assay also discriminated deer chronic wasting disease and sheep scrapie brain samples from normal control samples. In principle, end-point dilution quantitation can be applied to many types of prion and amyloid seeding assays. End point dilution RT-QuIC provides a sensitive, rapid, quantitative, and high throughput assay of prion seeding activity. Public Library of Science 2010-12-02 /pmc/articles/PMC2996325/ /pubmed/21152012 http://dx.doi.org/10.1371/journal.ppat.1001217 Text en This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Wilham, Jason M.
Orrú, Christina D.
Bessen, Richard A.
Atarashi, Ryuichiro
Sano, Kazunori
Race, Brent
Meade-White, Kimberly D.
Taubner, Lara M.
Timmes, Andrew
Caughey, Byron
Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays
title Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays
title_full Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays
title_fullStr Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays
title_full_unstemmed Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays
title_short Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays
title_sort rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996325/
https://www.ncbi.nlm.nih.gov/pubmed/21152012
http://dx.doi.org/10.1371/journal.ppat.1001217
work_keys_str_mv AT wilhamjasonm rapidendpointquantitationofprionseedingactivitywithsensitivitycomparabletobioassays
AT orruchristinad rapidendpointquantitationofprionseedingactivitywithsensitivitycomparabletobioassays
AT bessenricharda rapidendpointquantitationofprionseedingactivitywithsensitivitycomparabletobioassays
AT atarashiryuichiro rapidendpointquantitationofprionseedingactivitywithsensitivitycomparabletobioassays
AT sanokazunori rapidendpointquantitationofprionseedingactivitywithsensitivitycomparabletobioassays
AT racebrent rapidendpointquantitationofprionseedingactivitywithsensitivitycomparabletobioassays
AT meadewhitekimberlyd rapidendpointquantitationofprionseedingactivitywithsensitivitycomparabletobioassays
AT taubnerlaram rapidendpointquantitationofprionseedingactivitywithsensitivitycomparabletobioassays
AT timmesandrew rapidendpointquantitationofprionseedingactivitywithsensitivitycomparabletobioassays
AT caugheybyron rapidendpointquantitationofprionseedingactivitywithsensitivitycomparabletobioassays